PRECLINICAL TRIALS USING AN IMMUNOCONJUGATE OF T101 AND METHOTREXATE IN AN ATHYMIC MOUSE HUMAN T-CELL TUMOR-MODEL

被引：0
|
作者：
SHAWLER, DL
JOHNSON, DE
SWEET, MD
MYERS, LJ
TUDOR, SD
BEIDLER, DE
KOZIOL, JA
DILLMAN, RO
机构：
[1] BIOTHERAPEUT INC,LA JOLLA,CA
[2] HYBRITECH INC,SAN DIEGO,CA
[3] UNIV CALIF SAN DIEGO,CTR CANC,SAN DIEGO,CA 92103
[4] SCRIPPS CLIN & RES FDN,LA JOLLA,CA 92037
[5] VET ADM MED CTR,SAN DIEGO,CA 92161
来源：
JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | 1988年 / 7卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：608 / 618
页数：11
相关论文
共 50 条
  • [41] Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool
    Lemmermann, Niels A. W.
    Reddehase, Matthias J.
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2016, 205 (06) : 549 - 561
  • [42] Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with ‘humanized’ antigen presentation as a new preclinical study tool
    Niels A. W. Lemmermann
    Matthias J. Reddehase
    Medical Microbiology and Immunology, 2016, 205 : 549 - 561
  • [43] LONG-TERM PERSISTENCE OF HUMAN ANTI-MURINE ANTIBODY-RESPONSES FOLLOWING RADIOIMMUNODETECTION AND RADIOIMMUNOTHERAPY OF CUTANEOUS T-CELL LYMPHOMA PATIENTS USING I-131 T101
    GOLDMANLEIKIN, RE
    KAPLAN, EH
    ZIMMER, AM
    KAZIKIEWICZ, J
    MANZEL, LJ
    ROSEN, ST
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (10) : 861 - 864
  • [44] SUPPRESSION AND RESTORATION OF CYTOTOXIC T-CELL ACTIVITY DURING CHEMOTHERAPY OF A MOUSE T-CELL LYMPHOMA AND A MACROPHAGE TUMOR
    TARNOWSKI, GS
    FAANES, RB
    RALPH, P
    WILLIAMS, N
    CANCER RESEARCH, 1978, 38 (12) : 4540 - 4545
  • [45] Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinoma
    Yuexin Xu
    Alicia J. Morales
    Michael J. Cargill
    Andrea M. H. Towlerton
    David G. Coffey
    Edus H. Warren
    Scott S. Tykodi
    Cancer Immunology, Immunotherapy, 2019, 68 : 1979 - 1993
  • [46] Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinoma
    Xu, Yuexin
    Morales, Alicia J.
    Cargill, Michael J.
    Towlerton, Andrea M. H.
    Coffey, David G.
    Warren, Edus H.
    Tykodi, Scott S.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (12) : 1979 - 1993
  • [47] Understanding the complexity of γδ T-cell subsets in mouse and human
    Pang, Dick J.
    Neves, Joana F.
    Sumaria, Nital
    Pennington, Daniel J.
    IMMUNOLOGY, 2012, 136 (03) : 283 - 290
  • [48] EARLY STAGES IN HUMAN AND MOUSE T-CELL DEVELOPMENT
    SPITS, H
    CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (02) : 212 - 221
  • [49] EFFICACY OF AN ANTI-CD7-RICIN-A CHAIN IMMUNOCONJUGATE IN A NOVEL MURINE MODEL OF HUMAN T-CELL LEUKEMIA
    FISHWILD, DM
    ABERLE, S
    BERNHARD, SL
    KUNG, AHC
    CANCER RESEARCH, 1992, 52 (11) : 3056 - 3062
  • [50] COEXPRESSION OF HUMAN T-CELL RECEPTOR CHAINS WITH MOUSE CD3 ON THE CELL-SURFACE OF A MOUSE T-CELL HYBRIDOMA
    ZUMLA, A
    MARGUERIE, C
    SO, A
    YOKOYAMA, WM
    SAITO, T
    BATCHELOR, JR
    LECHLER, RI
    JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 149 (01) : 69 - 76
12345